All Type of News
AZ Korea fully pushing marketing efforts for Atacand sales.
AstraZeneca Korea celebrated a launching event for Atacand as the first day of "Atacand Day" in attendance of more than 100 company staffs related with the cardiovascular drug business areas at the head office located...
Another father-son fight on March 29?
Following Dong-A Pharmaceutical's shareholders' meeting to be scheduled on March 29, some market watchers are wondering whether the firm is going into another round of the father-son dispute for control.
Dong-A Pha...
GSK to employ Korean doctors as key Asian regional position.A prestige of Korean medical doctors seems to surge up in the multinational drug corporations, appointing a key medical director in the Asia and Pacific regions.
GSK said on...
|
Assembly mulls bill to correct suspicious prescription next month
A medical bill that doctors or dental doctors should explain any suspicious contents of a prescription raised by a pharmacist will be under consideration in the National Assembly's special session on April.
Accordi...
Kim Young-chan named KFDA regional director in Pusan
The Korea Food and Drug Administration on March 19 nominated director of Kwangju's KFDA agency Kim Young-chan, to be the new director of KFDA agency in Pusan.
The KFDA also appointed Head of Toxicology Institute Ki...
Hyundai to launch new Norevo emergent contraceptive.Hyundai announced that an emergent contraceptive drug called "Norevo 2T" would be soon launched with a renovated one tablet product under the new name of "Norevo One Tab".
No...
|
Pharmacies troubled with short shelf-life inventories.
The retail pharmacies have faced many business difficulties with the stocks whose shelf lives were closer to the end, most of them being found from the products supplied by foreign multinational drug corporations inc...
Doctors threaten strike over billTension between the government and medical circles is expected to reach a crisis point this week as more than 100,000 doctors, dentists, oriental doctors and nurses' aides will ...
|
New guideline set for clinical trial GMP
The Korea Food and Drug Administration said that it has recently set up a new guideline about procedures and obligations for the manufacture and quality control of drugs to be used in clinical trials, as part of its e...
Abbott and Eisai to launch Humira, rheumatoid arthritis therapy.Abbott Korea and Eisai Korea jointly launched a new type of rheumatoid arthritis drug called "Humira", having mode of selectively suppressing the TNF-alfa that linked with the o...
|
